Arch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Update

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the target of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 12,400 shares, a decrease of 6.1% from the November 15th total of 13,200 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 1.4 days.

Arch Therapeutics Price Performance

ARTH opened at $0.23 on Wednesday. The business has a fifty day simple moving average of $0.27 and a 200-day simple moving average of $0.58. Arch Therapeutics has a fifty-two week low of $0.17 and a fifty-two week high of $9.00.

About Arch Therapeutics

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.